drugset / Trial / NCT00645853
Long-term Safety in Atrial Fibrillation Patients
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to provide safety and tolerability data for AZD0837 during long-term treatment (5 years) in patients with non-valvular atrial fibrillation (AF) and one or more additional risk factors for stroke and systemic embolic events (moderate to high risk patients).
Timeline
- Start
- 2007-10
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATECEGATRAN METOXIL | Small molecule | 300 mg | Oral |
| Comparator | Warfarin | Small molecule | — | — |